Compendium of Cancer Genome Aberrations

STBT5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(25 intermediate revisions by 3 users not shown)
Line 229: Line 229:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|Minimal genetic content added
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
Line 251: Line 251:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|10/16/2025
|
|Katie Schieffer
|
|10/16/2025
|
|No genetic association
|-
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|[[STBT5:Elastofibroma|Elastofibroma]]
Line 293: Line 293:
|9/21/2025
|9/21/2025
|12/21/2025
|12/21/2025
|PENDING
|COMPLETE
|
|9/22/2025
|
|Katie Schieffer
|
|9/22/2025
|
|No genetic association
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
Line 311: Line 311:
|-
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/16/2025
|
|Katie Schieffer
|
|10/16/2025
|
|No genetic association
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|Disease
|
|
Line 378: Line 378:
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/21/2025
|
|Katie Schieffer
|
|10/21/2025
|
|
|-
|-
Line 420: Line 420:
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|No genetic association
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
Line 453: Line 453:
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Disease
|
|Kati
|
e Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|Minimal genetic content added
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
Line 517: Line 518:
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Disease
|
|Yiting Li (trainee);
|
Shashirekha Shetty (mentor)
|
|9/24/2025
|
|12/24/2025
|
|COMPLETE
|
|12/18/2025
|
|Katie Schieffer
|12/18/2025
|
|
|-
|-
Line 539: Line 541:
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/10/2025
|
|Katie Schieffer
|
|12/10/2025
|
|No genetic association
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
Line 561: Line 563:
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Disease
|
|Mokhtar Abdelhammed, MD (trainee);
|
Katie Schieffer (mentor)
|
|3/1/2026
|
|6/30/2026
|PENDING
|
|
|
|
Line 658: Line 661:
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|No genetic association
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/10/2025
|Katie Schieffer
|11/10/2025
|No genetic association
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|Disease
|
|
Line 678: Line 714:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|Disease
|
|
Line 689: Line 736:
|
|
|-
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|Disease
|
|
Line 700: Line 747:
|
|
|-
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 711: Line 767:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|Disease
|
|
Line 722: Line 778:
|
|
|-
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
Line 730: Line 808:
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 744: Line 822:
|
|
|-
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|
|
|
|
|
|
Line 764: Line 833:
|
|
|-
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
Line 775: Line 844:
|
|
|-
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 786: Line 855:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|Disease
|
|
Line 797: Line 866:
|
|
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 808: Line 886:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|Disease
|
|
Line 819: Line 897:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 830: Line 908:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|Disease
|
|
Line 841: Line 930:
|
|
|-
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|Disease
|
|
Line 852: Line 941:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|
|
Line 863: Line 952:
|
|
|-
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 883: Line 963:
|
|
|-
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 894: Line 974:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 905: Line 985:
|
|
|-
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 916: Line 1,005:
|
|
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|Disease
|
|
Line 927: Line 1,016:
|
|
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|Disease
|
|
Line 938: Line 1,027:
|
|
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 949: Line 1,038:
|
|
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|Disease
|
|
Line 960: Line 1,049:
|
|
|-
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 971: Line 1,060:
|
|
|-
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|
|
Line 982: Line 1,071:
|
|
|-
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|
|
|
|
Line 1,002: Line 1,082:
|
|
|-
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 1,013: Line 1,093:
|
|
|-
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/11/2025
|
|Katie Schieffer
|
|12/11/2025
|
|No genetic association
|-
|-
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|Consider linking to CNS tumor book
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|
|
|
|
Line 1,034: Line 1,142:
|
|
|
|
|-
|
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|
|
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|Disease
|
|
Line 1,046: Line 1,157:
|
|
|-
|-
|[[STBT5:Schwannoma|Schwannoma]]
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|
Line 1,057: Line 1,168:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 1,068: Line 1,179:
|
|
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|Disease
|
|
Line 1,079: Line 1,190:
|
|
|-
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|Disease
|
|
Line 1,090: Line 1,212:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|Disease
|
|
Line 1,110: Line 1,232:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 1,121: Line 1,243:
|
|
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|Disease
|
|
Line 1,132: Line 1,254:
|
|
|-
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 1,143: Line 1,265:
|
|
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|9/11/2025
|12/11/2025
|COMPLETE
|12/29/2026
|Katie Schieffer
|1/7/2026
|
|
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
Line 1,161: Line 1,299:
|
|
|
|
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|PENDING
|
|
|Katie Schieffer
|
|
|
|
|-
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 1,176: Line 1,322:
|
|
|-
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|Disease
|
|
Line 1,187: Line 1,333:
|
|
|-
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|Disease
|
|Maxine Sutcliffe, PhD
|
|10/13/2025
|
|12/31/2025
|
|COMPLETE
|
|12/24/2025
|
|Katie Schieffer
|
|12/24/2025
|
|
|-
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|Disease
|
|
Line 1,229: Line 1,364:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,240: Line 1,375:
|
|
|-
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|Disease
|Maxine Sutcliffe, PhD
|1/12/2026
|4/12/2026
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|
|
|
|
|
|
|
|-
|[[STBT5:PEComa|PEComa]]
|Disease
|
|
|
|
Line 1,261: Line 1,404:
|
|
|
|
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|Mokhtar Abdelhammed, MD
|9/11/2025
|12/11/2025
|PENDING
|
|
|Katie Schieffer
|
|
|
|
|-
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,284: Line 1,419:
|
|
|-
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|Disease
|
|
Line 1,295: Line 1,430:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|PENDING
|
|
|Katie Schieffer
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
|-
----
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|10/1/2023
|12/9/2025
|PENDING
|
|Katie Schieffer
|
|
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|Disease
|
|
Line 1,328: Line 1,473:
|
|
|-
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Disease
|
|
Line 1,339: Line 1,484:
|
|
|-
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|Disease
|
|
Line 1,359: Line 1,504:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|
|
|
|
|
|
|
|
----
|
|
----
|-
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|No genetic association
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|-
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,403: Line 1,569:
|
|
|-
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,414: Line 1,602:
|
|
|-
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|Disease
|
|
Line 1,425: Line 1,613:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
----
|
----
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|Sadeem Qdaisat
|Katie Schieffer
|10/1/23
|9/21/2025
|12/9/2025
|12/31/2025
|PENDING
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|
|Working with Eric McGinnis
|
|2021 template added
|-
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|
|
Line 1,468: Line 1,646:
|
|
|-
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,479: Line 1,666:
|
|
|-
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,490: Line 1,677:
|
|
|-
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
|
----
|
----
|
|
----
|-
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,531: Line 1,699:
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,542: Line 1,710:
|
|
|-
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,553: Line 1,721:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:Osteoma|Osteoma]]
|Disease
|Disease
|
|
Line 1,564: Line 1,732:
|
|
|-
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|Disease
|
|
Line 1,575: Line 1,743:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|Disease
|
|
Line 1,586: Line 1,754:
|
|
|-
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|Disease
|
|
Line 1,597: Line 1,765:
|
|
|-
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Fang Fang (trainee); Katie Schieffer (mentor)
|11/19/2025
|2/15/2026
|PENDING
|
|Katie Schieffer
|
|
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,608: Line 1,796:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,619: Line 1,807:
|
|
|-
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|Disease
|
|
Line 1,630: Line 1,818:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|Disease
|
|
Line 1,641: Line 1,829:
|
|
|-
|-
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,661: Line 1,840:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,672: Line 1,851:
|
|
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|Disease
|
|
Line 1,683: Line 1,873:
|
|
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|Disease
|
|
Line 1,694: Line 1,884:
|
|
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,705: Line 1,904:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|
|
Line 1,716: Line 1,915:
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
Line 1,727: Line 1,926:
|
|
|-
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,738: Line 1,937:
|
|
|-
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|Disease
|
|
Line 1,749: Line 1,948:
|
|
|-
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|Disease
|
|
Line 1,760: Line 1,959:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association, early genetic studies referenced
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Disease
|
|
Line 1,780: Line 1,981:
|
|
|-
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|11/14/2025
|
|Katie Schieffer
|
|11/14/2025
|
|No genetic association
|-
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/22/2025
|Katie Schieffer
|10/22/2025
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|
Line 1,813: Line 2,023:
|
|
|-
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|
|-
|
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,835: Line 2,056:
|
|
|-
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|Refer to lipoma and hibernoma pages in STBT book
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to leiomyosarcoma page in STBT book
|
|-
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|Disease
|
|
Line 1,857: Line 2,089:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/21/2025
|
|Katie Schieffer
|
|10/21/2025
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to plasmacytoma page in heme book
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
Line 2,115: Line 2,120:
|
|
|
|
|
|Refer to heme book
|-
|-
|-
|-
Line 2,135: Line 2,140:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
Line 2,146: Line 2,151:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
Line 2,157: Line 2,162:
|
|
|
|
|
|Refer to heme book
|-
|-
|
|
Retrieved from "https://test.ccga.io/index.php/STBT5:Volunteer_Assignments_and_Opportunities"